DTHF Partners with Coral Healthcare

Coral Healthcare (India & Australia) have undertaken to provide their top quality condoms to the DTHF as their commitment to being, “proactive doers in the worlds in which we function”. We eagerly look forward to the first consignment that should arrive at the end of October. An Agreement has been signed between the DTHF and…

Dolutegravir Access: Achieved!

At the UN General Assembly meeting Michel Sidibe, Executive Director of UNAIDS, announced that an exciting new pricing agreement has been made to accelerate the availability of the first affordable, generic, single-pill HIV treatment, which will contain Dolutegravir. A potent integrase inhibitor, Dolutegravir is an antiretroviral drug championed due to its low risk of side…

Busting Myths about PrEP

 PrEP is an everyday pill that an HIV negative person can take to prevent getting HIV. Consistent use is essential for protection. Since PrEP is still a relatively new advancement in HIV prevention technology, there are still a lot of concerns and misconceptions around it. Fortunately, there has been a flurry of research in the…

Researchers Present at IAS 2017

The International AIDS Symposium (IAS) Conference 2017 was a wealth of cutting edge research and discussion on HIV and AIDS, and the representatives from the Desmond Tutu HIV Foundation (DTHF) were no exception. Opening the conference was our own Prof Linda-Gail Bekker, the IAS President and International Scientific Chair of IAS 2017. Bekker spoke about…